The predicted share price (Closing Price) for Par Drugs & Chemicals Ltd for tomorrow (2026-04-23) is ₹87.76 which is 11.65% higher than today’s share price of ₹78.60
Par Drugs & Chemicals Ltd – Investor Insights
Valuation StatusiCompares the stock's intrinsic value (calculated from fundamentals like earnings, book value, and growth) with the current market price (CMP). Undervalued = potential buying opportunity. Overvalued = the market may be pricing in too much optimism.
Undervalued
Intrinsic ₹119.78 vs CMP ₹78.60 (+52.4%)
Market RegimeiShows whether the stock is in an uptrend (bullish) or downtrend (bearish) based on its Exponential Moving Average (EMA). When price is above EMA → bullish momentum. Below EMA → bearish pressure. This affects how our model adjusts volatility and predictions.
▼ Bearish
Price/EMA: 0.743 · EMA(252): ₹105.78
VolatilityiMeasures how much the stock price swings. Low (<25%) = stable, predictable price movement. Moderate (25-40%) = normal for most stocks. High (>40%) = large daily swings, higher risk. The "recent trend" shows if volatility is currently increasing or decreasing compared to its historical average.
60.6% annualized
Risk: High · Recent trend: Falling (recent < historical)
Trend MemoryiThe Hurst Exponent measures whether price movements tend to continue (trending) or reverse (mean-reverting). Above 0.55 = momentum persists, recent trends likely to continue. Below 0.45 = price tends to snap back after big moves. Around 0.5 = random walk, past moves don't predict future direction.
Trending (persistent)
Hurst exponent: 0.559
Projected CAGRiCompound Annual Growth Rate — the average yearly return if the stock reaches our projected price target. 5Y and 10Y show different time horizons. Higher CAGR = faster expected growth. Negative CAGR = the model projects the stock may decline from current levels.
-0.4%5Y+0.1%10Y
Historical drift: -62.2% annualized
Risk-Reward RatioiCompares your potential upside (to intrinsic value) against potential downside (to fundamental floor). Above 2x = favorable risk-reward, potential gain is at least double the potential loss. Below 1x = unfavorable, you risk losing more than you could gain. A negative value means the stock is already above intrinsic value.
0.58x
Upside +52.4% vs downside 91% · Unfavourable
Margin of SafetyiA concept from value investing (Benjamin Graham). It measures how much cheaper the stock is compared to its intrinsic value. Positive margin = you're buying below fair value (safety cushion). Negative margin = you're paying more than the stock is fundamentally worth. Most value investors look for at least 15-25% margin of safety.
+34.4%
Strong margin
Model ConfidenceiShows how reliable our predictions are for this stock. Based on the model's average prediction error over the last 90 days. Low error = high confidence. Also shows data coverage — more data points over longer periods produce more reliable projections. The model self-learns by adjusting parameters every 7 days.
Moderate
Avg error: 2.81% · 453 data points over 607 days
Fundamental FlooriThe lowest price the stock is expected to reach under normal market conditions, based on book value and financial strength (ROE, ROCE, debt ratios). A very low floor relative to CMP means the company has limited tangible asset backing at current prices. In extreme market crashes, prices can temporarily breach this level.
₹7.10
(91% below CMP)
52-Week Range
iShows the stock's lowest and highest closing prices over the past year (~252 trading days). The marker shows where today's price sits within that range. Near the low = potential value opportunity or ongoing weakness. Near the high = momentum or possible overextension.
₹78.60
₹122.00
CMP: ₹78.600% into range35.6% below 52W high
Monthly Return DistributioniBased on historical monthly returns (~21 trading days per month). Shows how many months the stock went up vs down, the best and worst single-month returns, and the win rate. A win rate above 55% with a positive average return indicates consistent performance. High best/worst spread = volatile returns.
Convergence TimelineiShows how long the model expects the stock price to take to converge toward its intrinsic value. The model uses a mathematical convergence rate that pulls the projected price toward intrinsic value gradually. Milestones show the expected price at 25%, 50%, 75%, and 100% convergence. For overvalued stocks, convergence means the price may decline toward intrinsic value.
Target: ₹119.78 in ~5.0 years (2031)
Now ₹7925% ₹8950% ₹9975% ₹109Target ₹120
Gap: 52.4% upward · Model convergence rate: 5.0 years
What this means: Par Drugs & Chemicals Ltd appears undervalued by 52.4% based on fundamentals. The stock is currently in a bearish regime (price below EMA). A Hurst exponent of 0.56 indicates trending behavior — recent price momentum is likely to persist. Volatility is high (60.6% annualized), implying wider price swings and higher risk.
Par Drugs & Chemicals Ltd Year-Wise Share Price Target (2027–2036)
Year
Projected Price (₹)
Growth %
CAGR
2027
80.42
+2.3%
+2.3%
Month
Projected Price (₹)
Jan
78.47
Feb
78.69
Mar
77.98
Apr
78.57
May
78.73
Jun
78.71
Jul
79.41
Aug
78.54
Sep
79.54
Oct
79.08
Nov
79.74
Dec
80.42
2028
79.40
+1.0%
+0.5%
Month
Projected Price (₹)
Jan
80.38
Feb
80.44
Mar
80.69
Apr
80.15
May
80.41
Jun
80.05
Jul
79.83
Aug
79.52
Sep
80.03
Oct
80.17
Nov
80.00
Dec
79.40
2029
79.93
+1.7%
+0.6%
Month
Projected Price (₹)
Jan
80.11
Feb
79.51
Mar
80.34
Apr
79.83
May
79.50
Jun
79.39
Jul
79.71
Aug
80.72
Sep
81.23
Oct
81.10
Nov
80.13
Dec
79.93
2030
77.36
-1.6%
-0.4%
Month
Projected Price (₹)
Jan
79.02
Feb
79.21
Mar
79.13
Apr
79.85
May
80.11
Jun
79.88
Jul
79.78
Aug
78.22
Sep
77.62
Oct
77.39
Nov
77.07
Dec
77.36
2031
77.10
-1.9%
-0.4%
Month
Projected Price (₹)
Jan
77.06
Feb
77.31
Mar
77.38
Apr
77.12
May
77.36
Jun
76.68
Jul
76.81
Aug
77.24
Sep
77.05
Oct
77.07
Nov
77.06
Dec
77.10
2032
76.67
-2.5%
-0.4%
Month
Projected Price (₹)
Jan
76.73
Feb
76.15
Mar
76.97
Apr
76.97
May
77.19
Jun
77.36
Jul
77.19
Aug
77.95
Sep
78.12
Oct
78.08
Nov
77.01
Dec
76.67
2033
78.26
-0.4%
-0.1%
Month
Projected Price (₹)
Jan
77.34
Feb
77.41
Mar
77.39
Apr
77.79
May
78.07
Jun
79.18
Jul
79.47
Aug
79.18
Sep
79.37
Oct
77.87
Nov
78.00
Dec
78.26
2034
78.47
-0.2%
0.0%
Month
Projected Price (₹)
Jan
78.55
Feb
78.37
Mar
79.01
Apr
78.08
May
78.03
Jun
78.05
Jul
77.67
Aug
77.65
Sep
77.55
Oct
78.04
Nov
78.55
Dec
78.47
2035
77.44
-1.5%
-0.2%
Month
Projected Price (₹)
Jan
77.61
Feb
77.29
Mar
76.65
Apr
77.08
May
76.70
Jun
76.93
Jul
77.00
Aug
77.11
Sep
76.89
Oct
77.21
Nov
77.72
Dec
77.44
2036
79.37
+1.0%
+0.1%
Month
Projected Price (₹)
Jan
77.92
Feb
78.19
Mar
78.19
Apr
78.62
May
78.85
Jun
78.24
Jul
78.26
Aug
78.00
Sep
78.07
Oct
79.03
Nov
79.18
Dec
79.37
Par Drugs & Chemicals Ltd Stock Price Analysis
Avg Error (MAPE)iMean Absolute Percentage Error — the average difference between predicted and actual prices, expressed as a percentage. Lower is better. Below 2% = excellent, 2-5% = good, above 5% = the model struggles with this stock.
3.52%
Direction AccuracyiHow often the model correctly predicted whether the price would go up or down the next day. Above 55% = good (better than a coin flip). Above 60% = strong. This matters more than exact price accuracy for trading decisions.
69.2%
Avg Error (₹)iThe average rupee difference between predicted and actual closing prices. For a ₹100 stock, an error of ₹2 means predictions are typically off by about 2%. This gives you a sense of the prediction's precision in absolute terms.
₹5.28
PredictionsiTotal number of daily predictions made for this stock. More predictions = more data for accuracy metrics. The model self-learns and adjusts its parameters every 7 days, so accuracy typically improves over time.
260
Par Drugs & Chemicals Ltd – Historical Performance vs Predictions
Par Drugs & Chemicals Ltd – 3-Month Price Forecast
Will Par Drugs & Chemicals Ltd share price increase tomorrow?
Par Drugs & Chemicals Ltd share price is expected to increase to ₹87.76 on 2026-04-23, which is 11.65% higher than today's price of ₹78.60. This prediction is based on our AI-powered GFBM model.
What is the intrinsic value of Par Drugs & Chemicals Ltd?
Par Drugs & Chemicals Ltd intrinsic value is ₹119.78, which is 52.39% above the current price of ₹78.60. This suggests the stock is currently undervalued.
What is the share price target of Par Drugs & Chemicals Ltd in 2027?
Par Drugs & Chemicals Ltd share price target for 2027 is projected to reach ₹80.42 by year-end (range: ₹77.98 to ₹80.42), representing a 2.32% increase from the current price of ₹78.60.
What is the share price target of Par Drugs & Chemicals Ltd in 2028?
Par Drugs & Chemicals Ltd share price target for 2028 is projected to reach ₹79.40 by year-end (range: ₹79.40 to ₹80.69), representing a 1.02% increase from the current price of ₹78.60.
What is the share price target of Par Drugs & Chemicals Ltd in 2029?
Par Drugs & Chemicals Ltd share price target for 2029 is projected to reach ₹79.93 by year-end (range: ₹79.39 to ₹81.23), representing a 1.69% increase from the current price of ₹78.60.
Should I buy Par Drugs & Chemicals Ltd stock now?
Based on current analysis, Par Drugs & Chemicals Ltd appears to be a consider buying candidate. Intrinsic value is ₹119.78 vs CMP ₹78.60. This is not investment advice — consult a SEBI-registered advisor before making investment decisions.
What is the fundamental floor price for Par Drugs & Chemicals Ltd?
The fundamental floor price for Par Drugs & Chemicals Ltd is ₹7.10, calculated from book value and financial strength metrics (ROE, ROCE, debt-to-equity, interest coverage). This is the theoretical minimum price under normal market conditions.
Par Drugs & Chemicals Ltd Share Price Prediction – How We Calculate the Targets
We calculate the share price targets for Par Drugs & Chemicals Ltd using a combined approach of Geometric Fractional Brownian Motion (GFBM) and the Exponential Moving Average (EMA) for trend analysis. This hybrid model incorporates historical price data, memory effects through the Hurst exponent, and dynamic regime shifts based on the stock's trends. Below are the detailed steps of how these projections are calculated.
Step 1: Calculate the Log Returns
The log returns measure the relative change in stock prices over time. It is calculated as follows:
The Hurst exponent measures the "memory" or persistence of the stock price movement. It is calculated as follows:
\[ H = \frac{\log(R/S)}{\log(n)} \]
Step 6: Project Future Share Prices Using GFBM and EMA
The future price of the stock is projected using a combined model of Geometric Fractional Brownian Motion (GFBM) and Exponential Moving Average (EMA) for trend-based regime switching.
Step 7: Predicting Tomorrow's Stock Price for Par Drugs & Chemicals Ltd
The predicted price for tomorrow is derived using the Geometric Brownian Motion (GBM) formula with drift, volatility, and a random factor to simulate market movements.
Step 8: Projected Share Prices for the Next 10 Years
The projected share prices for the next 10 years are calculated using the combined GFBM and EMA model, taking into account historical growth, volatility, and market trends.
Conclusion
Our hybrid approach provides a realistic projection of share prices for Par Drugs & Chemicals Ltd over the next 10 years by considering historical performance, volatility, market memory, and current trends.
The projected stock prices are provided for informational purposes only and do not constitute investment advice or recommendations. Past performance of securities is not indicative of future results. Getaka Financial Technology is not responsible for any investment decisions made on the basis of this information. Investors are advised to seek independent financial advice from a SEBI-registered investment advisor before making any investment decisions. Investments in the securities market are subject to market risks. Please read all associated offer documents and terms carefully before investing.